RESEARCH & DEVELOPMENT
Axio envisages a future where contemporary knowledge of biomaterials, medicine and engineering will be integrated in designing novel solutions to address the huge unmet need in management of trauma and chronic-infectious wounds.
We are a deep science medtech company with extensive R&D expertise in biomaterials. Our platform-based approach enables us to develop medical products that are engineered to enhance its efficacy even at higher scale. With such a vision, we introduced our first line of haemostatic products that are probably one of the best available trauma heamostats in the market today.
Axio’s research philosophy is to translate the biomaterials research into real-world products and bring them to patients’ bedside at an affordable cost. Here innovation is a daily practice as we explore unchartered territories in novel materials and technologies. The research & development team at Axio is developing novel solutions that are smarter, friendlier and quicker than the conventional products.